Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer

被引：32
|
作者：
Ligumsky, Hagai [1 ,6 ]
Dor, Herut [6 ]
Etan, Tal [1 ]
Golomb, Inbal [1 ,6 ]
Nikolaevski-Berlin, Alla [1 ]
Greenberg, Inbal [6 ]
Halperin, Tamar [2 ]
Angel, Yoel [3 ,6 ]
Henig, Oryan [4 ,6 ]
Spitzer, Avishay [1 ,6 ,7 ]
Slobodkin, Marina [5 ,6 ]
Wolf, Ido [1 ,6 ]
机构：
[1] Tel Aviv Sourasky Med Ctr, Oncol Div, IL-6423906 Tel Aviv, Israel
[2] Tel Aviv Sourasky Med Ctr, Human Immunodeficiency Virus Lab, IL-6423906 Tel Aviv, Israel
[3] Tel Aviv Sourasky Med Ctr, Dept Anasthesia Pain & Intens Care, IL-6423906 Tel Aviv, Israel
[4] Tel Aviv Sourasky Med Ctr, Dept Infect Dis & Infect Control, IL-6423906 Tel Aviv, Israel
[5] Tel Aviv Sourasky Med Ctr, Dept Internal Med D, IL-6423906 Tel Aviv, Israel
[6] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[7] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel
来源：
LANCET ONCOLOGY | 2022年 / 23卷 / 02期
关键词：
D O I：
10.1016/S1470-2045(21)00715-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：193 / 195
页数：3
相关论文
共 50 条
  • [31] BNT162b2 Vaccine Booster and Covid-19 Mortality
    Arbel, Ronen
    Sergienko, Ruslan
    Hammerman, Ariel
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (10) : 1000 - 1001
  • [32] Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod
    Capuano, Rocco
    Altieri, Manuela
    Conte, Miriana
    Bisecco, Alvino
    D'Ambrosio, Alessandro
    Donnarumma, Giovanna
    Grimaldi, Elena
    Coppola, Nicola
    Medici, Nicola
    Galdiero, Massimiliano
    Tedeschi, Gioacchino
    Gallo, Antonio
    JOURNAL OF NEUROLOGY, 2022, 269 (12) : 6185 - 6192
  • [33] Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents
    Pablo Montejano-Hervás
    Javier Gómez-Pavón
    Olga Tornero-Torres
    Mª Victoria Valverde-Moyar
    Beatriz Martín Cruz
    Maribel Vela Carbonera
    Raquel Fuentes-Irigoyen
    Pilar Tejada González
    Margarita González-Becerra
    Esther Higueras Sánchez
    Primitivo Ramos Cordero
    Drugs & Aging, 2022, 39 : 587 - 595
  • [34] Safety of BNT162b2 mRNA vaccine booster in the setting of Ad26.COV2.S-associated VITT
    Abou-Ismail, Mouhamed Yazan
    Kanack, Adam J.
    Splinter, Noah P.
    Smock, Kristi J.
    Moser, Karen A.
    Padmanabhan, Anand
    BLOOD ADVANCES, 2022, 6 (18) : 5327 - 5329
  • [35] Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
    Shashar, Moshe
    Nacasch, Naomi
    Grupper, Ayelet
    Benchetrit, Sydney
    Halperin, Tamar
    Erez, Daniel
    Rozenberg, Ilan
    Shitrit, Pnina
    Sela, Yaron
    Wand, Ori
    Cohen-Hagai, Keren
    AMERICAN JOURNAL OF NEPHROLOGY, 2022, 53 (2-3) : 207 - 214
  • [36] Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
    Zurac, Sabina
    Vladan, Cristian
    Dinca, Octavian
    Constantin, Carolina
    Neagu, Monica
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [37] Immunogenicity of the BNT162b2 mRNA vaccine in heart transplant recipients - a prospective cohort study
    Itzhaki Ben Zadok, Osnat
    Shaul, Aviv A.
    Ben-Avraham, Binyamin
    Yaari, Vicky
    Ben Zvi, Haim
    Shostak, Yael
    Pertzov, Barak
    Eliakim-Raz, Noa
    Abed, Galia
    Abuhazira, Miriam
    Barac, Yaron D.
    Mats, Israel
    Kramer, Mordechai R.
    Aravot, Dan
    Kornowski, Ran
    Ben-Gal, Tuvia
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (09) : 1555 - 1559
  • [38] Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents
    Montejano-Hervas, Pablo
    Gomez-Pavon, Javier
    Tornero-Torres, Olga
    Valverde-Moyar, Ma Victoria
    Martin Cruz, Beatriz
    Vela Carbonera, Maribel
    Fuentes-Irigoyen, Raquel
    Tejada Gonzalez, Pilar
    Gonzalez-Becerra, Margarita
    Higueras Sanchez, Esther
    Ramos Cordero, Primitivo
    DRUGS & AGING, 2022, 39 (07) : 587 - 595
  • [39] Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
    Levy, Itzchak
    Wieder-Finesod, Anat
    Litchevsky, Vladyslav
    Biber, Asaf
    Indenbaum, Victoria
    Olmer, Liraz
    Huppert, Amit
    Mor, Orna
    Goldstein, May
    Levin, Einav Gal
    Hod, Tammy
    Cohen, Carmit
    Lustig, Yaniv
    Rahav, Galia
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (12) : 1851 - 1855
  • [40] Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
    Sabina Zurac
    Cristian Vladan
    Octavian Dinca
    Carolina Constantin
    Monica Neagu
    Scientific Reports, 12
12345